Ulhas M. Pandurangi

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Emil Hagström, Philippe Gabríel Steg, Michael Szarek et al. · Circulation · 2022 · 112 citations · Full text

Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society

Aditya Kapoor, Ulhas M. Pandurangi, Vanita Arora et al. · Indian Pacing and Electrophysiology Journal · 2020 · 95 citations · Full text

Cardiovascular Toxicity, Cardiovascular Disease, Cardiovascular Risks +10

Electrocardiographic Comparison of Ventricular Arrhythmias in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy and Right Ventricular Outflow Tract Tachycardia

Kurt S. Hoffmayer, Orlando N. Machado, Gregory M. Marcus et al. · Journal of the American College of Cardiology · 2011 · 73 citations

Ventricular Arrhythmias, Heart Failure, Cardiomyopathy +13

Pre-operative short-term pulmonary rehabilitation for patients of chronic obstructive pulmonary disease undergoing coronary artery bypass graft surgery.

Aiswarya Rajendran, Ulhas M. Pandurangi, Renuka Murali et al. · PubMed · 1999 · 48 citations

Risk scoring system to predict contrast induced nephropathy following percutaneous coronary intervention

Suma M. Victor, Anand Gnanaraj, Sethu Vijayakumar et al. · Indian Heart Journal · 2014 · 41 citations · Full text

Percutaneous Coronary Intervention, Cardiovascular Disease, Medicine +12